tiprankstipranks
Annovis Bio (ANVS)
NYSE:ANVS

Annovis Bio (ANVS) Cash flow

379 Followers

Annovis Bio Cash Flow

ANVS's free cash flow for Q3 2023 was $-9.37M. For the 2023 fiscal year, ANVS's free cash flow was decreased by $-8.18M and operating cash flow was $-9.37M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -34.21M$ -17.31M$ -9.13M$ -3.97M$ -476.54K$ -558.61K
Investing Cash Flow
------
Financing Cash Flow
$ 8.58M$ 4.61K$ 46.74M$ 12.04M$ 443.09K$ 246.45K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 65.82M$ 28.38M$ 45.69M$ 8.07M$ 1.86K$ 35.31K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 8.57M-$ 46.65M$ 12.03M$ 0.00$ 246.45K
Issuance Of Debt
---$ 0.00$ 530.00K$ 0.00
Repayment Of Debt
------
Free Cash Flow
$ -34.21M$ -17.31M$ -9.13M$ -3.97M$ -476.54K$ -558.61K
Domestic Sales
------
Foreign Sales
------
Currency in USD

Annovis Bio Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis